2-amino-3,4-dimethylimidazo(4,5-f)quinoline has been researched along with 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chipman, JK; Doehmer, J; Edwards, GO; Lautraite, S; Musonda, AC | 1 |
1 other study(ies) available for 2-amino-3,4-dimethylimidazo(4,5-f)quinoline and 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
Article | Year |
---|---|
Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1.
Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Animals; Anticarcinogenic Agents; Apigenin; Benzo(a)pyrene; Biotransformation; Carcinogens; Cells, Cultured; Comet Assay; Cricetinae; Cricetulus; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; DNA Adducts; DNA Damage; Enzyme Inhibitors; Fibroblasts; Flavonoids; Humans; Liver; Lung; Male; Mutagenicity Tests; Prodrugs; Quercetin; Quinolines; Rats; Rats, Wistar; Recombinant Fusion Proteins; Species Specificity | 2002 |